Samsung Biologics, Launching ‘S-Cellerate’, CDO Acceleration Platform
Small-and-medium-sized Business/Ventu
Samsung Biologics has unveiled ‘S-Cellerate’, a contract development organization(CDO) platform that dramatically shortens the period from cell line development to IND submission and from process characterization(PC) to biologics license application(BLA).
![LG그룹[T01] [NSPAD]LG그룹](https://file.nspna.com/ad/T01_lgfuture_5298.gif)
![삼성전자[T01] [NSPAD]삼성전자](https://file.nspna.com/ad/T01_samsung_5043.gif)